Prostate Cancer Reports
54

Volume 6 Supplement 1
January 2018

.

Home > Prostate Cancer Reports > Volume 6, Year 2018 > Supplement 1, January



CONTENTS



DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS



Abdel-Rahman O.
Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
PLoS One. 2017 Nov 28;12(11):e0188450. doi: 10.1371/journal.pone.0188450. eCollection 2017.
Source | Abstract | Full text | Similar articles




Decazes P, Thureau S, Dubray B, Vera P.
How to use PET/CT in the evaluation of response to radiotherapy.
Q J Nucl Med Mol Imaging. 2017 Nov 28. doi: 10.23736/S1824-4785.17.03033-3. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hoffmann MA, Taymoorian K, Ruf C, Gerhards A, Leyendecker K, Stein T, Jakobs FM, Schreckenberger M.
Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer.
Anticancer Res. 2017 Dec;37(12):6871-6877.
Source | Abstract | Full text | Similar articles




Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL.
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.
J Clin Oncol. 2017 Nov 29:JCO2017742940. doi: 10.1200/JCO.2017.74.2940. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Udovicich C, Perera M, Hofman MS, Siva S, Del Rio A, Murphy DG, Lawrentschuk N.
68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends.
Prostate Int. 2017 Dec;5(4):125-129. doi: 10.1016/j.prnil.2017.02.003. Epub 2017 Feb 24.
Source | Abstract | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION



Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.
Mortality results from a randomized prostate-cancer screening trial.
N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.
Source | Abstract | Full text | Similar articles | Erratum




Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators.
Screening and prostate-cancer mortality in a randomized European study.
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
Source | Abstract | Full text | Similar articles




Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, Feuer EJ, de Koning HJ, Mariotto AB, Etzioni R.
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Ann Intern Med. 2017 Oct 3;167(7):449-455. doi: 10.7326/M16-2586. Epub 2017 Sep 5.
Source | Abstract | Full text | Similar articles




Vickers AJ.
Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms.
Ann Intern Med. 2017 Oct 3;167(7):509-510. doi: 10.7326/M17-2012. Epub 2017 Sep 5.
Source | Abstract | Full text | Similar articles




Zolot J.
Study Finds Overall Prostate Cancer Mortality Decreases with PSA Screening.
Am J Nurs. 2017 Dec;117(12):16. doi: 10.1097/01.NAJ.0000527472.38965.1f.
Source | Abstract | Full text | Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY



Egevad L, Delahunt B, Kristiansen G, Samaratunga H, Varma M.
Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.
Pathology. 2018 Jan;50(1):60-73. doi: 10.1016/j.pathol.2017.09.008. Epub 2017 Dec 6.
Source | Abstract | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE



Capogrosso P, Ventimiglia E, Cazzaniga W, Stabile A, Pederzoli F, Boeri L, Gandaglia G, Dehò F, Briganti A, Montorsi F, Salonia A.
Long-term penile morphometric alterations in patients treated with robot-assisted versus open radical prostatectomy.
Andrology. 2017 Dec 1. doi: 10.1111/andr.12446. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Machen GL, Rajab MH, Pruszynski J, Coffield KS.
Phosphodiesterase type 5 inhibitors usage and prostate cancer: a match-paired analysis.
Transl Androl Urol. 2017 Oct;6(5):879-882. doi: 10.21037/tau.2017.06.02.
Source | Abstract | Full text | Similar articles



INTEGRATIVE MEDICINE



Bauer SR, Van Blarigan EL, Stampfer MJ, Chan JM, Kenfield SA.
Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study.
Prostate. 2017 Dec 1. doi: 10.1002/pros.23457. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Xiao Y, Zhang S, Tong H, Shi S.
Comprehensive evaluation of the role of soy and isoflavone supplementation in humans and animals over the past two decades.
Phytother Res. 2017 Nov 29. doi: 10.1002/ptr.5966. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



OVERALL MANAGEMENT



Carlaw KR, Woo HH.
Evaluation of the changing landscape of prostate cancer diagnosis and management from 2005 to 2016.
Prostate Int. 2017 Dec;5(4):130-134. doi: 10.1016/j.prnil.2017.04.005. Epub 2017 Apr 28.
Source | Abstract | Full text | Similar articles




Matulewicz RS, Weiner AB, Schaeffer EM.
Active Surveillance for Prostate Cancer.
JAMA. 2017 Dec 5;318(21):2152. doi: 10.1001/jama.2017.17222.
Source | Abstract | Full text | Similar articles




Cadeddu JA.
Low-Risk Disease: AUA/ASTRO/SUO guideline. (Slides)
Published 2017 May 12-16. American Urological Association website.
Source | Abstract | Full text | Similar articles




Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR.
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.
J Urol. 2017 Dec 14. pii: S0022-5347(17)78003-2. doi: 10.1016/j.juro.2017.11.095. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sanda MG.
Intermediate-Risk Disease: AUA/ASTRO/SUO guideline. (Slides)
Published 2017 May 12-16. American Urological Association website.
Source | Abstract | Full text | Similar articles




Taplin MH.
High-Risk Disease: AUA/ASTRO/SUO guideline. (Slides)
Published 2017 May 12-16. American Urological Association website.
Source | Abstract | Full text | Similar articles



PROGNOSIS



Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ.
Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Eur Urol. 2017 Nov 28. pii: S0302-2838(17)30995-8. doi: 10.1016/j.eururo.2017.11.012. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Stephenson AJ, Kattan MW.
Nomograms for prostate cancer.
BJU Int. 2006 Jul;98(1):39-46. DOI: 10.1111/j.1464-410X.2006.06173.x Epub 2006 Jun 8.
Source | Abstract | Full text | Similar articles




Yang DD, Mahal BA, Muralidhar V, Vastola ME, Boldbaatar N, Labe SA, Nezolosky MD, Orio PF 3rd, King MT, Martin NE, Mouw KW, Trinh QD, Nguyen PL.
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.
Clin Genitourin Cancer. 2017 Nov 8. pii: S1558-7673(17)30329-4. doi: 10.1016/j.clgc.2017.10.013. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



TREATMENT



Bayliss DR, Duff J, Stricker P, Walker K.
Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.
Urol Nurs. 2017 Jan-Feb;37(1):15-22.
Source | Abstract | Full text | Similar articles




Loeb S.
Active Surveillance Offers Functional Advantages Without Impacting Survival for Low-risk Prostate Cancer.
Eur Urol. 2017 Nov 20. pii: S0302-2838(17)30976-4. doi: 10.1016/j.eururo.2017.10.037. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




McClelland S 3rd, Sandler KA, Degnin C, Chen Y, Mitin T.
Active Surveillance for Low and Intermediate Risk Prostate Cancer: Opinions of North American Genitourinary Oncology Expert Radiation Oncologists.
Clin Genitourin Cancer. 2017 Nov 7. pii: S1558-7673(17)30337-3. doi: 10.1016/j.clgc.2017.10.021. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Nguyen PL.
Value of Extra-Early Initiation of Salvage Radiation for Increasing Prostate-Specific Antigen After Prostatectomy.
J Clin Oncol. 2016 Sep 6. pii: JCO690396. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ost P, Reynders D, Decaestecker K, Fonteyne V, Lumen N, De Bruycker A, Lambert B, Delrue L, Bultijnck R, Claeys T, Goetghebeur E, Villeirs G, De Man K, Ameye F, Billiet I, Joniau S, Vanhaverbeke F, De Meerleer G.
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.
J Clin Oncol. 2017 Dec 14:JCO2017754853. doi: 10.1200/JCO.2017.75.4853. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Penson DF.
Re: Treatment Decision Regret among Long-Term Survivors of Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study.
J Urol. 2017 Dec;198(6):1200. doi: 10.1016/j.juro.2017.09.058. Epub 2017 Sep 15.
Source | Abstract | Full text | Similar articles